Tretten Kit
Product Images NDC 0169-7013

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Tretten (NDC 0169-7013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Tretten 2500 Iu Carton (Export 00)

Label for TRETTEN 2500 IU kit containing Coagulation Factor XIII A-Subunit (Recombinant) by Novo Nordisk. The label includes usage instructions, ingredients, and images of two vials. It shows the NDC 0169-7013-01 and specifies that it is for intravenous administration only and Rx only.*

FDA Label Image

Tretten Vial And Adapter (F4607f56 9618 4a12 A047 C0de02cafe05 01)

An instructional diagram showing components of a TRETTEN kit, including a water vial with white plastic cap and rubber stopper, a powder vial with orange plastic cap and rubber stopper, and a vial adapter consisting of a protective cap, protective paper, tip, and spike.*

FDA Label Image

Remoal Of The Protective Paper (F4607f56 9618 4a12 A047 C0de02cafe05 03)

An instructional illustration showing a hand removing a protective seal from the top of a small vial or bottle, with a downward arrow indicating the direction of removal. The image likely relates to preparation or usage steps for a pharmaceutical kit.*

FDA Label Image

Attach The Vial Adapter (F4607f56 9618 4a12 A047 C0de02cafe05 04)

An instructional illustration showing a hand grasping the top of a vial with a flip-off cap. The image includes an upward arrow indicating the removal of the cap from the vial. A smaller inset highlights the capped vial, emphasizing the cap removal step.*

FDA Label Image

Draw Back The Plunger (F4607f56 9618 4a12 A047 C0de02cafe05 05)

An instructional illustration showing two hands holding a syringe-like device. One hand stabilizes the device, while the other hand's thumb presses down on a plunger or stopper, indicated by an arrow pointing downward. The image suggests an action to push or depress the plunger.*

FDA Label Image

Screw The Syringe (F4607f56 9618 4a12 A047 C0de02cafe05 06)

Instructional illustration showing two hands preparing a syringe by attaching or twisting its tip onto another component, likely part of the TRETTEN coagulation factor XIII A-subunit recombinant kit setup process.*

FDA Label Image

Inject Air From The Plunger (F4607f56 9618 4a12 A047 C0de02cafe05 07)

An instructional illustration showing a hands-on step involving a syringe and vial, likely related to preparation or administration of TRETTEN, a Coagulation Factor XIII A-Subunit (Recombinant) kit by Novo Nordisk. One hand holds the vial inverted while the other hand pushes a plunger on the syringe, indicated by a downward arrow.*

FDA Label Image

Remove The Empty Diluent Vial (F4607f56 9618 4a12 A047 C0de02cafe05 08)

An instructional illustration showing two hands connecting a syringe to a vial or connector. A bold arrow points to the connection point, indicating the step of attaching or securing the syringe during preparation. This image is likely part of the instructions for use for TRETTEN, a Coagulation Factor XIII A-Subunit recombinant plasma derivative kit by Novo Nordisk.*

FDA Label Image

Attach The Syringe To The Powder Vial (F4607f56 9618 4a12 A047 C0de02cafe05 09)

An instructional illustration showing a hand holding a syringe with an arrow indicating the plunger being pushed down, likely demonstrating preparation or administration technique for the TRETTEN coagulation factor XIII A-subunit recombinant kit.*

FDA Label Image

Gently Swirl The Vial (F4607f56 9618 4a12 A047 C0de02cafe05 10)

Illustration showing a hand holding a syringe that is being twisted or screwed onto a vial, indicated by a rotating arrow around the vial, likely demonstrating preparation or assembly of the medication kit.*

FDA Label Image

Tretten Vials (F4607f56 9618 4a12 A047 C0de02cafe05 11)

An instructional diagram showing two types of vials included in the TRETTEN kit by Novo Nordisk. The water vial features a white plastic cap and a rubber stopper, while the powder vial has an orange plastic cap and a rubber stopper. The diagram visually distinguishes the contents by vial type.*

FDA Label Image

Vial Adapter (F4607f56 9618 4a12 A047 C0de02cafe05 12)

An instructional diagram showing a vial adapter with labeled parts including the protective cap, protective paper, tip, and spike. The diagram illustrates the components of the vial adapter used with TRETTEN, a coagulation factor XIII A-subunit recombinant plasma derivative kit by Novo Nordisk.*

FDA Label Image

Figure A (F4607f56 9618 4a12 A047 C0de02cafe05 13)

Illustration showing a hand removing a protective seal from the top of a medication vial, demonstrating the initial step in preparing the product for use.*

FDA Label Image

Figure B (F4607f56 9618 4a12 A047 C0de02cafe05 14)

An instructional illustration showing a hand gripping and lifting a vial cap vertically upward. The vial is positioned on a surface, with an inset image in the lower right corner showing a close-up of the vial cap.*

FDA Label Image

Figure C (F4607f56 9618 4a12 A047 C0de02cafe05 15)

An instructional diagram showing a person holding a syringe, with a hand pulling off a protective cap from the needle. This image is likely part of usage instructions for the TRETTEN coagulation factor XIII A-subunit recombinant kit by Novo Nordisk.*

FDA Label Image

Figure D (F4607f56 9618 4a12 A047 C0de02cafe05 16)

An instructional illustration showing a person using a syringe to draw liquid from a vial, with an arrow indicating the direction of the syringe's movement. This likely demonstrates part of the preparation process for using the TRETTEN coagulation factor XIII A-subunit recombinant kit by Novo Nordisk.*

FDA Label Image

Figure E (F4607f56 9618 4a12 A047 C0de02cafe05 17)

An instructional illustration showing a hand holding a syringe or vial, with an arrow indicating a downward motion to connect or push a component. The image likely depicts a step in the preparation or use of the TRETTEN KIT by Novo Nordisk.*

FDA Label Image

Figure F (F4607f56 9618 4a12 A047 C0de02cafe05 18)

An instructional illustration showing hands connecting a syringe to a vial or component, indicating attachment or assembly, with a bold arrow emphasizing the connection point. The image likely guides preparation or administration steps for the TRETTEN kit containing Coagulation Factor XIII A-Subunit (Recombinant).*

FDA Label Image

Figure G (F4607f56 9618 4a12 A047 C0de02cafe05 19)

An instructional diagram showing a hand holding a syringe attached to a vial or container. An arrow indicates the motion to push or pull the syringe plunger, suggesting preparation or mixing of the medication.*

FDA Label Image

Figure H (F4607f56 9618 4a12 A047 C0de02cafe05 20)

An instructional illustration showing a hand holding a syringe and attaching it to a vial. The image includes a curved arrow indicating a twisting or screwing motion to connect the syringe to the vial, likely part of the preparation steps for the TRETTEN coagulation factor XIII A-subunit recombinant kit by Novo Nordisk.*

FDA Label Image

Figure I (F4607f56 9618 4a12 A047 C0de02cafe05 21)

An instructional illustration showing a hand holding a syringe connected to a vial with a downward arrow indicating an action involving the syringe, likely part of preparation steps for the TRETTEN coagulation factor XIII A-subunit recombinant kit by Novo Nordisk.*

FDA Label Image

Figure J (F4607f56 9618 4a12 A047 C0de02cafe05 22)

An instructional illustration showing hands attaching or twisting a syringe to a vial or another medical device, demonstrating a step in the preparation or administration of a medication kit.*

FDA Label Image

Figure K (F4607f56 9618 4a12 A047 C0de02cafe05 23)

Illustration showing components of a medical kit, including a syringe with a tube, a vial adapter with a circular seal, and two small vials. The diagram depicts the assembly or connection process for preparing medication, likely indicating steps for reconstitution or injection.*

FDA Label Image

Vial Label (F4607f56 9618 4a12 A047 C0de02cafe05 25)

TRETTEN Coagulation Factor XIII A-Subunit (Recombinant) 2500 IU kit label from Novo Nordisk. The label specifies intravenous use only, storage at 2-8°C, and reconstitution with 3.2 mL sterile water for injection. Includes NDC 0169-7113-11 and contact phone number for Novo Nordisk.*

FDA Label Image

Sterile Water For Injection (F4607f56 9618 4a12 A047 C0de02cafe05 26)

The image shows a label for Sterile Water for Injection, 3.2 mL, used for reconstitution of TRETTEN, which contains Coagulation Factor XIII A-Subunit (Recombinant). The label indicates storage conditions at 2-25°C (36-77°F). The product is labeled by Novo Nordisk and includes the NDC number 0169-7000-93 and a customer service contact.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.